| curl-6 said: 2 COVID-19 vaccines have now reached Phase III trials. (Large scale efficacy testing) 7 others are in Phase II, (expanded safety trials) 7 more are in Phase I, (first stage testing) and another 125 are in in the pre-clinical stage. https://www.nytimes.com/interactive/2020/science/coronavirus-vaccine-tracker.html |
Production is already starting to ramp up, not waiting for the trials to finish
https://www.ctvnews.ca/health/coronavirus/astrazeneca-agrees-to-make-covid-19-vaccine-for-europe-1.4983059
AstraZeneca struck a deal Saturday to supply up to 400 million doses of an experimental COVID-19 vaccine to European Union countries. The Anglo-Swedish company recently completed similar agreements with Britain, the United States, the Coalition for Epidemic Preparedness Innovations, a public-private-charitable partnership based in Norway, and Gavi, the Vaccine Alliance, another public-private partnership headquartered in Geneva, for 700 million doses. It plans to produce an additional 1 billion doses under a deal with the Serum Institute of India.
The vaccine was developed by Oxford University's Jenner Institute, working with the Oxford Vaccine Group. Testing of the experimental COVID-19 vaccine began in April with a study involving over 1,000 healthy volunteers in Britain aged 18 to 55. Another round of testing with 10,000 volunteers began last month.
Other companies, including Moderna and Sanofi, are racing to develop and produce a vaccine to protect against the new coronavirus, a step experts say will be crucial to allowing countries to ease public health lockdowns and restrictions on public life.
Essay Pro